je.st
news
Tag: clinical trials
J&J Ebola vaccine to start clinical trials in early 2015
2014-09-04 14:05:05| Biotech - Topix.net
Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson, in another sign that the world's worst outbreak of the virus is mobilising research into the deadly disease. J&J said on Thursday that clinical trials of its new vaccine, which includes technology from Danish biotech firm Bavarian Nordic, would commence in early 2015.
Tags: start
early
clinical
trials
J&J Ebola vaccine to start clinical trials in early 2015
2014-09-04 12:21:08| Food - Topix.net
Scientists will fast-track tests on another Ebola vaccine, this time from Johnson & Johnson, in another sign that the world's worst outbreak of the virus is mobilising research into the deadly disease. J&J said on Thursday that clinical trials of its new vaccine, which includes technology from Danish biotech firm Bavarian Nordic, would commence in early 2015.
Tags: start
early
clinical
trials
Pediatric Clinical Trials: Special Considerations and Requirements
2014-07-31 01:19:20| drugdiscoveryonline Home Page
Date: Monday, September 8, 2014 Time: 1pm - 2:30pm EDT Duration: 90 Minutes - Online Price: $299 - Introductory Rate
Tags: special
requirements
clinical
considerations
Lilly Announces Increased Access to Clinical Trials Data for Qualified Researchers
2014-06-02 19:44:11| Biotech - Topix.net
This website, which houses data from several clinical trial sponsors, was created in support of ongoing efforts by the Pharmaceutical Research and Manufacturers of America and the European Federation of Pharmaceutical Industries and Associations to increase access to and transparency of clinical trial results with researchers around the world.
Tags: data
access
increased
clinical
Furiex Pharmaceuticals Announces Positive Top-Line Results Of Two Pivotal Phase III Clinical Trials Of Eluxadoline In Patients With IBS-d
2014-02-05 07:38:22| drugdiscoveryonline Home Page
Furiex Pharmaceuticals, Inc. recently announced top-line results indicating the company’s two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain
Tags: with
results
iii
positive